InMed Pharmaceuticals INM
NASDAQ INM
$1.36 -0.01 (-1.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Total Non-Current Liabilities (2020 - 2021)

Updated

InMed Pharmaceuticals' Total Non-Current Liabilities was $166,549 in fiscal Q3 2021 (quarter ended Mar 31, 2021), down 93.0% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Total Non-Current Liabilities (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Linde 218.21 Bn 201.33 Bn 4.43 Bn 36.82 Bn
2 Corning 136.71 Bn 129.84 Bn 1.63 Bn 14.10 Bn
3 Sherwin Williams 80.23 Bn 79.27 Bn 3.34 Bn 20.50 Bn
4 Air Products & Chemicals 62.17 Bn 60.07 Bn 1.04 Bn 19.27 Bn
5 Corteva 51.95 Bn 40.75 Bn 3.66 Bn 5.45 Bn
6 LyondellBasell Industries 37.59 Bn 27.21 Bn 2.04 Bn 22.10 Bn
7 Nutrien 34.30 Bn 31.17 Bn 3.25 Bn 27.37 Bn
8 Qnity Electronics 26.28 Bn 23.71 Bn 666.00 Mn 5.75 Bn
9 Ati 25.72 Bn 23.87 Bn 309.80 Mn 3.41 Bn
10 InMed Pharmaceuticals 5.75 Mn 3.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 166,549.00
Dec 31, 2020 2.39 Mn
API Access

InMed Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INM&period=max&api_key=YOUR_API_KEY